Supriya Lifescience has informed that it enclosed a duly signed Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 received from Link Intime India, Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2022.
The above information is a part of company’s filings submitted to BSE.